NeuroBo Pharmaceuticals Cash from Financing (TTM) Analysis

NeuroBo Pharmaceuticals Inc (NRBO)

3.12 -0.25 (-7.42%) USD | NASDAQ | Apr 22, 16:00

3.05 -0.07 (-2.24%) After-Hours: 05:30

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-0.08M
September 30, 2023	28.74M
June 30, 2023	28.60M
March 31, 2023	28.68M
December 31, 2022	28.68M
September 30, 2022	12.75M
June 30, 2022	12.86M
March 31, 2022	12.93M
December 31, 2021	22.03M
September 30, 2021	9.14M
June 30, 2021	9.164M
March 31, 2021	15.90M
December 31, 2020	6.858M
September 30, 2020	6.859M
June 30, 2020	6.85M
March 31, 2020	24.22M
December 31, 2019	24.17M

Date	Value
September 30, 2019	18.28M
June 30, 2019	18.34M
March 31, 2019	-5.978M
December 31, 2018	17.25M
September 30, 2018	23.02M
June 30, 2018	33.12M
March 31, 2018	33.09M
December 31, 2017	21.34M
September 30, 2017	20.74M
June 30, 2017	37.76M
March 31, 2017	42.86M
December 31, 2016	31.46M
September 30, 2016	34.69M
June 30, 2016	10.24M
March 31, 2016	6.494M
December 31, 2015	8.736M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.08M

Minimum

Dec 2023

28.74M

Maximum

Sep 2023

16.58M

Average

15.90M

Median

Mar 2021

Cash from Financing (TTM) Benchmarks